Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri

American Journal of Medicine

Volumn 107, Issue 1, 1999, Pages 30-37

  McDonnell, Sharon M ^a   Hover, Alexander ^b   Gloe, Donna ^b   Ou, Chin Yih ^c   Cogswell, Mary E ^a   Grummer Strawn, Laurence ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b St John's Hospital   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ADULT; ARTICLE; DIAGNOSTIC VALUE; DNA DETERMINATION; EMPLOYEE; FEMALE; FERRITIN BLOOD LEVEL; GENETIC SCREENING; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

ADULT; DNA; FEMALE; GENOTYPE; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH PERSONNEL; HEMOCHROMATOSIS; HUMANS; IRON OVERLOAD; MALE; MASS SCREENING; MIDDLE AGED; MISSOURI; PHENOTYPE; POINT MUTATION; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK; SENSITIVITY AND SPECIFICITY; TRANSFERRIN;

EID: 0033166882     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00163-1     Document Type: Article

References (63)

1. Witte D.L., Crosby W.H., Edwards C.Q., Fairbanks V.F., Mitros F.A. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chem Acta. 245:1996;139-200.
2. Feder J.N., Penny D.M., Irrinki A., et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci. 95:1998;1472-1477.
3. Powell L.W., Summers K.M., Board P.G., Axelsen E., Webb S., Halliday J.W. Expression of hemochromatosis in homozygous subjects implications for early diagnosis and prevention . Gastroenterology. 98:1990;1625-1632.
4. Adams P.C., Valberg L.S. Evolving expression of hereditary hemochromatosis. Sem liver dis. 16:1996;47-54.
5. Grace N.D., Powell L.W. Iron storage disorders of the liver. Gastroenterology. 67:1974;1257-1283.
6. Adams P.C., Speechley M., Kertesc A.E. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology. 101:1991;368-372.
7. Niederau C., Fischer R., Purschel A., Stremmel W., Haussinger D., Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 110:1996;1107-1119.
8. Bradley L.A., Haddow J.E., Palomaki G.E. Population screening for haemochromatosis a unifying analysis of published intervention trials . J Med Screen. 3:1996;178-184.
9. Stuart K.E., Anand A.J., Jenkins R.L. Hepatocellular carcinoma in the United States. Cancer. 77:1996;2217-2222.
10. Launois B., Chauvin J., Machado M.L., Bourdonnec P., Campion J.P., Bardaxoglou E. Surgical treatment of hepatocarcinoma in cirrhosis. Ann Gastroenterol Hepatol. 32:1996;35-39.
11. Bell H., Skinningsrud, Raknerud N., Try K. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases. J Intern Med. 236:1994;315-322.
12. Piperno A., D'Alba R., Fargion S., et al. Liver iron concentration in chronic viral hepatitis a study of 98 patients . Eur J Gastroenterol Hepatol. 7:1995;1203-1208.
13. George D.K., Evans R.M., Crofton R.W., Gunn I.R. Testing for haemochromatosis in the diabetic clinic. Ann Clin Biochem. 32:1995;521-526.
14. Phelps G., Chapman I., Hall P., Braund W., MacKinnon M. Prevalence of genetic haemochromatosis among diabetic patients. Lancet. ii:1989;233-234.
15. Czinck E., Tamas G. Screening for idiopathic haemochromatosis among diabetic patients. Diabetes Care. 14:1991;929-930.
16. Singh B.M., Grunewald R.A., Press M., Muller B.R., Wise P.H. Prevalence of haemochromatosis amongst patients with diabetes mellitus. Diabet Med. 9:1992;730-731.
17. O'Brien T., Barrett B., Murray D.M., Dinneen S., O'Sullivan D.J. Usefulness of biochemical screening of diabetic patients for hemochromatosis. Diabetes Care. 13:1990;532-534.
18. Mananchino D., Andrea G., Ottinetti A., Martinotti R. Hemochromatosis and diabetes. Mayo Clin Proc. 69:1994;913.
19. Kaye T.B., Guay A.T., Simonson D.C. Non-insulin-dependent diabetes mellitus and elevated serum ferritin level. J Diabet Complications. 7:1993;246-249.
20. Dinneen S.F., Silverberg J.D., Batts K.P., O'Brien P.C., Ballard D.J., Rizza R.A. Liver iron stores in patients with non-insulin dependent diabetes mellitus. Mayo Clin Proc. 69:1994;13-15.
21. Olynyk J., Hall P., Ahern M., Kwiatek R., Mackinnon M. Screening for genetic haemochromatosis in a rheumatology clinic. Aust N Z J Med. 24:1994;588-589.
22. Conte D., Mananchino D., Colli A., et al. Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann Intern Med. 128:1998;370-373.
23. Yang Q., McDonnell S.M., Khoury M.J., Cono J., Parrish R.G. Hemochromatosis mortality in the United States, 1979-1992 an analysis of multiple cause mortality data . Ann Int Med. 129:1998;946-953.
24. Fairbanks VF, Baldus WP. Disorders of iron metabolism. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA, eds. Hematology, 4th ed. New York: McGraw-Hill, 1990:752-758.
25. Olsson K.S., Eriksson K., Ritter B., Heedman P.A. Screening for iron overload using transferrin saturation. Acta Med Scand. 215:1984;105-112.
26. Edwards C.Q., Griffen L.M., Goldgar D., Drummond C., Skolnick M.H., Kushner J.P. Prevalence of hemochromatosis among 11,065 presumably health blood donors. NEJM. 318:1988;1355-1362.
27. Niederau C., Niederau C.M., Lange S., et al. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med. 128:1998;337-345.
28. McDonnell S.M., Phatak P.D., Felitti V., Hover A., McLaren G.D. Screening for hemochromatosis in primary care settings. Ann Intern Med. 129:1998;962-970.
29. Centers for Disease Control and Prevention. Iron overload disorders among Hispanics - San Diego, California, 1995. MMWR 1996;45:991-993.
30. Edwards C.Q., Kushner J.P. Screening for hemochromatosis. NEJM. 328:1993;1616-1620.
31. Bulaj Z.J., Griffen L.M., Jorde L.B., Edwards C.Q., Kushner J.P. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. NEJM. 1996;1799-1805.
32. McLaren C.E., Gorduek V.R., Looker A.C., et al. Prevalence of heterozygotes for hemochromatosis in the white population in the United States. Blood. 86:1995;2021-2027.
33. McLaren C.E., McLachlan G.J., Halliday J.W., et al. Distribution of transferrin saturation in an Australian population relevance to the early diagnosis of hemochromatosis . Gastroenterology. 114:1998;543-549.
34. Edwards C.Q., Griffen L.M., Ajioka R.S., Kushner J.P. Screening for hemochromatosis phenotype versus genotype . Semin Hematol. 35:1998;72-76.
35. Bassett M.L., Halliday J.W., Ferris R.A., Powell L.W. Diagnosis of hemochromatosis in young subjects predictive accuracy of biochemical screening tests . Gastroenterology. 87:1984;628-633.
36. Cogswell M.E., McDonnell S.M., Khoury M.J., Franks A., Burke W., Brittenham G. Iron overload, public health and genetics evaluating the evidence for hemochromatosis screening . Ann Intern Med. 129:1998;971-979.
37. Edwards C.Q., Kushner J.P. Screening for hemochromatosis. NEJM. 328:1993;1616-1620.
38. Feder J.N., Gnirke A., Thomas W., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 13:1996;399-408.
39. Burke W., Thomson E., Khoury M., et al. Hereditary hemochromatosis gene discovery and its implications for population-based screening . JAMA. 280:1998;172-178.
40. Barton J.C., Harmon L., Rivers C., Action R.T. Hemochromatosis association of severity of iron overload with genetic markers . Blood Cells, Mol Dis. 22:1996;195-204.
41. Beutler E., Gelbart T., West C., et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis. 22:1996;187-194.
42. Burke W., Press N., McDonnell S.M. Hemochromatosis genetics helps to define a multifactoral disease . Clin Genet. 54:1998;1-9.
43. NHANESIII National Center for Health Statistics. Plan and operation of the third National Health and Nutrition Examination Survey, 1988-1994. Vital Health Stat 1994;1:94-1308. Hyattsville, MD: National Center for Health Statistics.
44. Expert Scientific Working Group . Summary of a report on assessment of the iron nutritional status of the United States population. Am J Clin Nutr. 42:1985;1318-1330.
45. Livak K., Flood S.J.A., Marmaro J., Giusti W., Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Meth Applic. 4:1995;357-362.
46. Perkin-Elmer. TaqMan Probe Design, Synthesis, and Purification. Foster City: Applied Biosystems Division, 1995.
47. Dean AG, Dean JA, Coulombier D, et al. Epi Info, version 6: a word processing, database, and statistics program for public health on IBM-compatible microcomputers. Atlanta: Centers for Disease Control and Prevention, 1995.
48. SAS Institute, Inc. SAS/STAT Users Guide, vol 1 and 2, version 6, 4th ed. Cary, NC: SAS Institute, 1989.
49. Bart M.J., George P.M., Upton J.D., et al. The significance of haemochromatosis gene mutations in the general population implications for screening . Gut. 43:1998;830-836.
50. Moirand R., Mortaji A.M., Loreal O., Paillard F., Brissot P., Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet. 349:1997;95-97.
51. Bassett M., Halliday J., Powell L. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 6:1986;24-29.
52. Kowdley K.V., Trainer T.D., Saltzman J.R., et al. Utility of hepatic iron index in American patients with hereditary hemochromatosis a multicenter study . Gastroenterology. 113:1997;1270-1277.
53. Powell L.W., George D.K., McDonnell S.M., Kowdley K. Diagnosis of hemochromatosis. Ann Intern Med. 129:1998;925-931.
54. Puolakka J. Serum ferritin in the evaluation of iron status in young healthy women. Acta Obstet Gynecol Scand. 95:1980;26-114.
55. Milman N., Sondergaard M. Iron stores in female blood donors evaluated by serum ferritin. Blut. 51:1985;337-345.
56. Milman N., Kirchhoff M. Iron stores in 1359, 30- to 60-year-old Danish women evaluation by serum ferritin and hemoglobin . Ann Hematol. 64:1992;22-27.
57. Milman N., Kirchhoff M. The influence of blood donation on iron stores assessed by serum ferritin and hemoglobin in a population survey of 1359 Danish women. Ann Hematol. 63:1991;27-32.
58. Finch C.A., Cook J.D., Labbe R.F., Culala M. Effect of blood donation on iron stores as evaluated by serum ferritin. Blood. 50:1977;441-447.
59. Garry P.J., Wayne S.J., Koehler K.M., Rathak D.R., Baumgartner R.N., Simon T.L. Prediction of iron absorption based on iron status of female blood donors. Am J Clin Nutr. 56:1992;691-698.
60. Cook J.D., Skikne B.S., Lynch S.R., Reusser M.E. Estimates of iron sufficiency in the US population. Blood. 3:1986;726-731.
61. Gunter EW, McDonnell SM. Transferrin saturation and screening of genetic hemochromatosis. Clin Chem 1998;44:361-362. Reply to letter to the editor.
62. Phatak P.D., Guzman G., Woll J., Robeson A., Phelps C.E. Cost effectiveness of screening for hereditary hemochromatosis. Arch Intern Med. 154:1994;769-776.
63. Adams P.C., Gregor J.C., Kertesz A.E., Valberg L.S. Screening blood donors for hereditary hemochromatosis decision analysis model based on a 30-year database . Gastroenterology. 109:1995;177-188.